BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37066414)

  • 1. Oral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.
    Choi SH; Myers J; Tomchuck S; Bonner M; Eid S; Kingsley D; VanHeyst K; Kim SJ; Kim BG; Huang AY
    Res Sq; 2023 Apr; ():. PubMed ID: 37066414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piceatannol Prevents Colon Cancer Progression via Dual-Targeting to M2-Polarized Tumor-Associated Macrophages and the TGF-β1 Positive Feedback Signaling Pathway.
    Chiou YS; Lan YM; Lee PS; Lin Q; Nagabhushanam K; Ho CT; Pan MH
    Mol Nutr Food Res; 2022 Aug; 66(15):e2200248. PubMed ID: 35616191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
    Choi J; Park J; Cho I; Sheen Y
    Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting transforming growth factor beta signaling in metastatic osteosarcoma.
    Ge R; Huang GM
    J Bone Oncol; 2023 Dec; 43():100513. PubMed ID: 38021074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. By targeting TRAF6, miR-140-3p inhibits TGF-β1-induced human osteosarcoma epithelial-to-mesenchymal transition, migration, and invasion.
    Guo Q; Zhang N; Liu S; Pang Z; Chen Z
    Biotechnol Lett; 2020 Nov; 42(11):2123-2133. PubMed ID: 32562135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma.
    Malek E; Rana PS; Swamydas M; Daunov M; Miyagi M; Murphy E; Ignatz-Hoover JJ; Metheny L; Seong Jin K; Driscoll JJ
    Res Sq; 2023 Jul; ():. PubMed ID: 37503043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDCD5 inhibits osteosarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with good prognosis.
    Zhao H; Peng C; Lu X; Guo M; Yang T; Zhou J; Hai Y
    Am J Transl Res; 2019; 11(2):1116-1128. PubMed ID: 30899411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
    Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
    Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease.
    Song KM; Chung DY; Choi MJ; Ghatak K; Minh NN; Limanjaya A; Kwon MH; Ock J; Yin GN; Kim DK; Ryu JK; Suh JK
    World J Mens Health; 2020 Oct; 38(4):552-563. PubMed ID: 31496148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
    Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors.
    Hong E; Barczak W; Park S; Heo JS; Ooshima A; Munro S; Hong CP; Park J; An H; Park JO; Park SH; La Thangue NB; Kim SJ
    Cell Death Dis; 2023 Feb; 14(2):93. PubMed ID: 36765032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting miR-29 induces apoptosis of osteosarcoma MG-63 cells via regulation of TGF-β1/PUMA signal.
    Wang CY; Ren JB; Liu M; Yu L
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3552-60. PubMed ID: 27649654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEAT1 induces osteosarcoma development by modulating the miR-339-5p/TGF-β1 pathway.
    Zhang L; Lu XQ; Zhou XQ; Liu QB; Chen L; Cai F
    J Cell Physiol; 2019 Apr; 234(4):5097-5105. PubMed ID: 30203547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
    Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
    Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway.
    Ye G; Jiao Y; Deng L; Cheng M; Wang S; Zhang J; Ouyang J; Li Y; He Y; Tu Z; Wang Z; Song X; Wang C; Qi Q; Zhang D; Wang L; Huang M; Ye W; Chen M
    Int J Biol Sci; 2023; 19(14):4376-4392. PubMed ID: 37781043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro Pre-Treatment of Cancer Cells with TGF-β1: A Novel Approach of Tail Vein Lung Cancer Metastasis Mouse Model for Anti-Metastatic Studies.
    Khan GJ; Sun L; Abbas M; Naveed M; Jamshaid T; Baig MMFA; Yuan S
    Curr Mol Pharmacol; 2019; 12(4):249-260. PubMed ID: 30848226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propofol suppresses invasion and induces apoptosis of osteosarcoma cell in vitro via downregulation of TGF-β1 expression.
    Xu YB; Jiang W; Zhao FR; Li G; Du QH; Zhang MY; Guo XG
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1430-5. PubMed ID: 27097968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.